Impact of Hospitalization and Medication Switching on Post‐discharge Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Impact of Hospitalization and Medication Switching on Post‐discharge Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation

Published:2020-09-21 Issue:10 Volume:40 Page:1022-1035
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Pham Nguyen Thanh Phuong¹²³⁴^ORCID,Chen Yong¹²⁴⁵⁶,Thibault Dylan³⁷,Leonard Charles E.¹²⁴^ORCID,Hennessy Sean¹²⁴⁸,Willis Allison¹²³⁴⁷

Affiliation:

1. Center for Pharmacoepidemiology Research and Training Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

2. Center for Clinical Epidemiology and Biostatistics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

3. Department of Neurology Translational Center for Excellence for Neuroepidemiology and Neurological Outcomes Research Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

4. Department of Biostatistics, Epidemiology, and Informatics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

5. Institute for Biomedical Informatics at the University of Pennsylvania Philadelphia Pennsylvania USA

6. Center for Evidence‐based Practice at the University of Pennsylvania Philadelphia Pennsylvania USA

7. Department of Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

8. Department of Systems Pharmacology and Translational Therapeutics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2457

Reference50 articles.

1. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation;January CT;Circulation,2019

2. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report;Lip GYH;Chest,2018

3. Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

4. Lexi‐Drugs Online. Available fromhttp://online.lexi.com/lco/action/home. Accessed June 29 2019.

5. Patient Education on Oral Anticoagulation

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral anticoagulant switching in patients with atrial fibrillation: a scoping review;BMJ Open;2023-04

2. Atypical antipsychotic use and mortality risk in Parkinson disease;Parkinsonism & Related Disorders;2022-10

3. Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN‐SPIDERS;British Journal of Clinical Pharmacology;2022-05-22

4. Low continuation of antipsychotic therapy in Parkinson disease – intolerance, ineffectiveness, or inertia?;BMC Neurology;2021-06-24

5. Direct Oral Anticoagulants versus Vitamin K Antagonists for Patients with Left Ventricular Thrombus: A Systematic Review and Meta-Analysis;Polish Archives of Internal Medicine;2021-04-07